Gapping up
In reaction to strong earnings/guidance: WEN +6.6% ( Q4 adj. EPS $0.10-0.11 vs $0.06 Capital IQ Consensus Estimate; North America Company-Operated Same-Restaurant-Sales up 3.1% in 4Q 2013; sees FY14 EPS $0.34-0.36 vs. $0.29 consensus), PLX +5.9%, (Provides FY2014 Strategic Outlook; says 'we expect to see sales of ELELYSO (taliglucerase alfa) increase across all approved and launched territories') CKSW +4.5%, ZLTQ +2.8%, SEM +2%, SEAS +1.9%, ALNY +1.3%.
M&A news: BEAM +26% (Beam acquired by Suntory Holdings for $83.50/share in cash), ALU +1.9% (reports out indicate co is considering sale of enterprise business unit), CHC halted (China Hydroelectric enters into a definitive agreement and Plan of Merger with CPT Wyndham; Parent will acquire the co for $1.17 per ordinary share or $3.51 per ADS).
Select financial related names showing strength: DB +3.2%, BCS +1.8%, UBS +1.8% (upgraded to Buy from Neutral at BofA/Merrill), IBN +1.6%, RBS +0.9%.
Select metals/mining stocks trading higher: MT +1.9%, EGO +1.8%, GOLD +1.2%.
Other news: TKMR +39.7% ( signs development agreement with Monsanto (MON) on delivery technology for agricultural applications), NPO +36% (estimates Garlock Sealing Technologies' mesothelioma liability at $125 mln ), NIHD +21.1% (Telefonica S.A. And NII Holdings sign agreements to provide wholesale voice and data services to nextel in Brazil And Mexico), CTIC +13.5% (reaches agreement to reacquire rights to two anti-cancer compounds from Novartis), CLVS +11.7% (following interview with Citi analyst on CNBC Friday night where he indicated company may be the next ICPT; also announces 2014 Objectives and financial guidance; 'expect to initiate three global registration studies for CO-1686 in first- and second-line mutant EGFR non-small cell lung cancer in the first half of 2014'; ended 2013 with $323 mln in cash), PLUG +9.6% (continued strength, to host conference call and webcast on January 16, 2014 to provide business update), RGLS +8.7% (Expands its Biomarkers Platform and Establishes Regulus microMarkers, a New R&D Division Focused on Identifying microRNAs as Biomarkers of Disease), SMI +8% (still checking), RSOL +7.5% (still checking for anything new; Mercury Solar Systems shareholders voted last week in favor of Real Goods Solar merger), STEM +5.8% (technology was featured January 10 in television segment on CTV News Channel and on the CTV National News), IDIX +5.2% (Reports Sustained Virologic Response Rate for Phase II All-Oral Combination Study of Samatasvir, a Potent, Pan-Genotypic HCV NS5A Inhibitor, and Simeprevir), QIHU +3.7% (still checking), DVAX +3.6% ( discloses it estimates it cash, cash equivalents, and marketable securities were ~$189 mln as of December 31, 2013), GALE +2.4% (Acquires Mills Pharmaceuticals; financial terms not disclosed; Acquisition adds GALE-401 (Anagrelide CR) to expand Galena's product pipeline), TTM +2.2% (still checking), CELG+1.8% (may be attributed to positive MadMoney comments), VTG +1.6% (announces update of Sigma joint venture: 'Sigma has informed STX that it will claim a refund of its payments made to the shipyard' ), MGA +1.6% ( following positive Barron's mention ), ALNY +1.3% (Alnylam Pharma and Sanofi's Genzyme form transformational alliance for RNAi Therapeutics as Genetic Medicines; Genzyme becomes major Alnylam shareholder through purchase of $700 mln of equity at $80/Share ; acquires investigational RNAi Therapeutic assets from Merck), AAL +0.6% ( Bids have been submitted for AAL slots at Reagan Airport; JBLU, DAL, LUV are interested, according to reports), CSCO +0.5% (Cisco Systems ticking higher following positive Barron's mention), CL +0.5% (may be attributed to positive MadMoney comments), CLF +0.4% ( Indonesia has banned iron ore exports, according to reports), SLM +0.3% (announces new $8 bln financing facility), GM +0.3% ( recalling 370k pickup tricks due to fire risk, according to reports; also General Motors plans to reintroduce dividend, according to reports), TGT +0.3% (Reuters discusses comments from Target (TGT) that the retailer is planning significant changes following data breach; Barron's profiles positive view on Target).
Analyst comments: NCR +5% (resumed with a Overweight at JP Morgan; added to Focus list ), QIHU +3.7% (upgraded to Buy at Stifel; tgt $108; year of search monetization), TWTR +3.5% ( positive Goldman comments and tgt price increase to $65 ), RHT +2.4% (upgraded to Overweight from Equal-Weight at Morgan Stanley), FTNT +2.2% (upgraded to Overweight from Equal-Weight at Morgan Stanley), FFIV +1.7% (upgraded to Outperform from Market Perform at William Blair), MGM +1.7% ( upgraded to Buy from Neutral at BofA/Merrill), ADSK +1.6% (upgraded to Overweight from Equal-Weight at Morgan Stanley), LPLA +1.3% (LPL Financial upgraded to Overweight from Neutral at JPMorgan ), DSX +1% (Diana Shipping upgraded to Buy from Hold at Deutsche Bank), V+1% (upgraded to Buy from Neutral at Citigroup), M +0.8% (Macy's upgraded to Outperform from Neutral at Macquarie ), F +0.8% (initiated with a Strong Buy at ISI Group), D +0.5% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
